Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy
about
Peroxisome proliferator-activated receptors for hypertension.Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.Activation of PPARδ: from computer modelling to biological effects.PPARγ ligands and their therapeutic applications: a patent review (2008 - 2014).Understanding PPAR-δ affinity and selectivity using hologram quantitative structure-activity modeling, molecular docking and GRID calculations.Multitargeted bioactive ligands for PPARs discovered in the last decade.How the ESRF helps industry and how they help the ESRF.SAR and Computer-Aided Drug Design Approaches in the Discovery of Peroxisome Proliferator-Activated ReceptorγActivators: A Perspective
P2860
Q34179017-4BE0EFAC-6BC1-446B-B6AE-0EEA4DFB7BD3Q35576545-085FC700-BBA0-4E5F-AADE-A5B953F3133BQ37737114-D6D6D737-F91E-4A7D-8E55-461B3DD39CC4Q38254275-B2257DF3-F706-4FF5-83ED-551B9FAA1245Q38270503-FE0AD3AC-CA58-46E9-B26B-363C7252F4D3Q38816007-5515C484-670E-40E0-86FC-6754C5694689Q38869029-654AE03F-FD75-4707-B214-31F0E5CC8CB4Q43018039-D038C8CB-48DB-4343-A907-F6F552F0126AQ58919671-2204118F-17C6-4738-9F91-0649547AE3DA
P2860
Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@ast
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@en
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@nl
type
label
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@ast
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@en
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@nl
prefLabel
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@ast
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@en
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@nl
P2093
P2860
P50
P356
P1433
P1476
Sulfonylthiadiazoles with an u ...... h potency and in vivo efficacy
@en
P2093
Hans Matter
Karl Schönafinger
Maike Glien
Matthias Urmann
Silke Haag-Diergarten
Stefanie Keil
Wolfgang Wendler
P2860
P304
P356
10.1002/CMDC.201100047
P577
2011-04-04T00:00:00Z